1. Home
  2. OSPN vs IVVD Comparison

OSPN vs IVVD Comparison

Compare OSPN & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$10.55

Market Cap

449.1M

Sector

Technology

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.72

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
IVVD
Founded
1991
2020
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
437.1M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
OSPN
IVVD
Price
$10.55
$1.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$16.67
$8.75
AVG Volume (30 Days)
550.2K
1.6M
Earning Date
01-01-0001
06-08-2026
Dividend Yield
4.86%
N/A
EPS Growth
28.77
79.02
EPS
1.88
N/A
Revenue
$243,180,000.00
$53,426,000.00
Revenue This Year
$3.12
$143.48
Revenue Next Year
$3.42
$25.40
P/E Ratio
$5.69
N/A
Revenue Growth
N/A
110.47
52 Week Low
$10.16
$0.46
52 Week High
$18.13
$3.07

Technical Indicators

Market Signals
Indicator
OSPN
IVVD
Relative Strength Index (RSI) 40.58 51.65
Support Level $10.26 $1.41
Resistance Level $11.68 $2.01
Average True Range (ATR) 0.41 0.11
MACD 0.02 0.04
Stochastic Oscillator 31.75 57.32

Price Performance

Historical Comparison
OSPN
IVVD

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: